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thickness (Tb.Th.), trabecular number (Tb.N) and trabecu-
lar spacing (Tb.Sp.)] were impaired in AN in the tibia (p 
values range < 0.01–0.0001). In the radius, BV/TV and 
Tb.N were lower (p < 0.05 and p < 0.001, respectively); 
Tb.Sp. was higher (p < 0.001), whereas Tb.Th. did not dif-
fer, compared to controls. Estimated failure load was lower 
in patients in both the radius and the tibia (p < 0.0005 and 
p < 0.0001, respectively), most pronounced in the tibia. In 
conclusion, the impairment of cortical thickness and esti-
mated failure load were significantly more pronounced in 
the weight-bearing tibia, compared to the non-weight-bear-
ing radius, implying a direct effect of low body weight on 
bone loss in AN.
Keywords Anorexia nervosa · High-resolution 
peripheral quantitative computed tomography · Bone 
microarchitecture · Bone geometry · Mechanical loading
Introduction
Anorexia nervosa (AN) is a psychiatric disorder affecting 
up to 2% of young women in the Western world [1]. The 
disease is characterized by low body weight due to self-
imposed weight loss (or resistance to weight gain), as well 
as a distorted self-image. The concomitant malnutrition 
is associated with several endocrine disturbances includ-
ing hypothalamic hypogonadism, hypercortisolemia and 
resistance to growth hormone, each of which is known to 
have deleterious effects in bone [2]. Accordingly, patients 
with AN have been shown to have decreased bone min-
eral density (BMD) [3], and impaired bone microarchi-
tecture, even with short duration of disease [4, 5]. What is 
of particular concern is the fact that the onset of AN often 
coincide with puberty [6], a critical period for the accrual 
Abstract Anorexia nervosa (AN) is associated with 
decreased bone mineral density and increased risk of 
fracture. The aim of this study was to assess bone geom-
etry, volumetric bone mineral density (vBMD), trabecular 
microarchitecture and estimated failure load in weight-
bearing vs. non-weight-bearing bones in AN. We included 
twenty-five females with AN, and twenty-five female con-
trols matched on age and height. Bone geometry, vBMD 
and trabecular microarchitecture were assessed using 
high-resolution peripheral quantitative computed tomog-
raphy of the distal radius and tibia. At both sites, cortical 
perimeter and total bone area were similar in patients and 
controls. Total vBMD was lower in the AN group in the 
tibia (p < 0.0005) but not in the radius. In the tibia, corti-
cal thickness was approximately 25% lower (p < 0.0005) in 
the AN group, whereas there was no significant difference 
in the radius. In terms of trabecular microarchitecture, all 
indices [bone volume/tissue volume (BV/TV); trabecular 
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of peak bone mass (PBM) [7], a known predictor for the 
development of osteoporosis [8]. Accordingly, a Danish 
register-based study found patients with AN to have an 
almost twofold relative risk for overall fracture and a sev-
enfold relative risk for hip fractures, compared to the gen-
eral population [9]. The mechanism behind bone loss in 
AN is undoubtedly multifactorial, and the abovementioned 
endocrine disturbances have been established as important 
factors. However, the role of body weight per se, and the 
mechanical load on the skeleton, is yet to be determined. 
It is well known that the skeleton has potential to adjust 
to changes in load, presumably with the osteocytes as the 
primary mechanosensing bone cells. When mechanical 
load increases, the secretion of sclerostin from osteocytes 
decreases, ultimately causing new bone formation by the 
osteoblast by stimulating the wnt/B-catenin signalling 
pathway [10]. In accordance, patients with AN have higher 
levels of sclerostin, lower levels of bone formation mark-
ers and higher levels of bone resorption markers, compared 
to controls [11]. One way to assess the effect of mechani-
cal loading in  vivo is to compare bone characteristics in 
weight-bearing vs. non-weight-bearing bones. To the best 
of our knowledge, such a comparison is yet to be made in 
patients with AN. When applying a similar approach to 
overweight patients referred to bariatric surgery, we have 
recently shown that obesity favours increased cortical area 
and cortical thickness (despite no significant difference in 
total bone area) in the tibia compared with normal weight, 
height-matched controls. The same pattern did not apply to 
the radius [12].
One major issue regarding the assessment of bone loss 
in AN is that areal BMD (aBMD) measurement is based 
on a 2-dimensional image, (dual-energy X-ray absorptiom-
etry, DXA) which to a certain degree fails to take weight 
loss-induced changes in extra-osseous fat distribution and 
bone marrow adiposity, into account [13]. The consequence 
is that BMD may be underestimated in the nadir-weight 
state, and overestimated upon subsequent weight-gain [13]. 
The introduction of high-resolution peripheral quantitative 
computed tomography (HR-pQCT) allows for 3-dimen-
sional (volumetric) assessment of BMD (vBMD), as well 
as compartment specific geometry and bone microarchi-
tecture. Although only assessed for quantitative computed 
tomography (QCT), the 3-dimensional technique seems to 
minimize the influence of fat distribution on BMD assess-
ment [14].
In this cross-sectional study, we therefore used both 
DXA and HR-pQCT to compare bone characteristics in 
patients with AN, with age- and height-matched control 
subjects. We hypothesized that aBMD, vBMD and bone 
microarchitecture would be significantly impaired in AN 
patients, compared to controls at all bone sites. We fur-
ther hypothesized that this impairment would be more 
pronounced in weight-bearing compared to non-weight-
bearing bones.
Subjects and Methods
Study Subjects
Patients were recruited from Centre for Eating Disorders, 
Odense University Hospital. Upon referral to the centre, all 
patients were diagnosed by a trained physician according to 
the ICD-10 diagnostic criteria for AN (body weight <85% 
of expected, self-induced weight-loss, distorted body image 
and amenorrhea). Inclusion criteria were female gender, 
Caucasian ethnicity, and age between 18 and 40 years. In 
order to reflect the population of patients with AN, and to 
ensure external validity, a minimum duration of disease 
of three  years was chosen. Exclusion criteria were other 
chronic diseases known to affect bone or medication affect-
ing bone metabolism. Estrogen-containing oral contracep-
tive pills (OCPs) were allowed.
Each AN case was matched with a control subject on 
height (±3 cm) and gender. Potential control subjects were 
randomly identified from a sample from the Danish Civil 
Registration Registry combining date of birth, gender and 
residence in the Municipality of Odense, Denmark. When 
responding to a written invitation to participate, potential 
controls declared their height to allow for correct match-
ing. Inclusion criteria for controls, in addition to matching 
criteria, were normal weight according to the WHO defini-
tion [15], and age within the same age-range as the patients 
(18–40  years). Exclusion criteria were amenorrhea (no 
menstrual bleeding for three or more consecutive months) 
of any cause, a history of any eating disorder and diseases 
known to affect bone or medications as stated above.
Prior to inclusion, we performed sample size calcula-
tion, based on the data provided by Ackerman and col-
leagues [16]. Based on trabecular number suggested inclu-
sion of 25 patients and 25 controls allows for an alpha of 
0.05 and a power of 80%.
DXA
DXA (Hologic, Discovery, Waltham, MA, US) of the hip 
and lumbar spine was used to assess bone mineral content 
(BMC) and aBMD at the femoral neck, trochanter region, 
total hip and lumbar spine (L1–L4). A whole body DXA 
scan was performed to obtain indices of body composition, 
including total fat mass and fat percentage. The coefficient 
of variation (CV) for hip and spine assessment is 1.5% in 
our unit.
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HR-pQCT
Values for bone geometry, compartment-specific vBMD 
and bone microarchitecture were obtained using a high-
resolution peripheral quantitative computed tomography 
system (HR-pQCT, XtremeCT; Scanco Medical, Zürich, 
Switzerland). Validation, correlation to μCT measurements 
and methods for parameter extraction from the images, has 
previously been reported by Laib et al. [17–19].
We applied the manufactures’ default protocol for in vivo 
imaging, which has been described in detail elsewhere 
[20]. Images of the non-dominant distal radius and the tibia 
were obtained, except in case of previous fracture, where 
the non-fractured limb was chosen. The subject’s forearm/
ankle was immobilized in a carbon fibre cast to decrease 
motion artefacts. Based on an initial 2D scout scan, the 
operator placed a reference line at the bone endplate and 
the region of interest initiated 9.5 mm and 22.5 mm from 
the radius and the tibia endplate, respectively, and extended 
9.02 mm in the proximal direction. Each region contained 
110 parallel slices with an 82-μm isotropic voxel size.
The operator immediately viewed the images for visual 
motion-artefacts, and up to two additional scans of each 
region was performed to secure the best possible quality of 
the scan.
Parameter extraction was performed in accordance with 
the manufactures protocol. In brief, scans were automati-
cally segmented into trabecular and cortical compartments, 
using a threshold-based algorithm [17], thereby providing 
information on cortical area, trabecular area, cortical thick-
ness (Ct.Th.) and compartment specific volumetric densi-
ties. Trabecular bone volume per tissue volume (BV/TV) 
was derived from trabecular vBMD under the assump-
tion of fully mineralized bone having a mineral density of 
1200 mg hydroxyapatite per  cm3. Assessment of trabecular 
number (Tb.N.) was based on direct determination of ridge 
number density and the principle of 3D distance transfor-
mation, as described by Laib et al. [18]. From BV/TV and 
Tb.N., trabecular thickness (Tb.Th.) and trabecular spacing 
(Tb.Sp.) was calculated as Tb.Th. = (BV/TV)/Tb.N. and 
Tb.Sp. = (1 − BV/TV)/Tb.N, respectively.
Assessment of cortical porosity (Co.Po.) was based on 
extended cortical evaluation, as described by Burghardt 
et al. [21], and calculated as void cortical volume divided 
by total cortical volume. Finally, estimated bone strength 
was calculated by Finite Element Analysis (FEA) soft-
ware, provided by the manufacturer (μFE Element Analy-
sis Solver v.1.15; Scanco Medical, Brüttisellen, Switzer-
land). In the FEA, an axial compression test was simulated, 
wherein failure load was defined as the force that will 
result in more than 2% of elements being strained beyond 
0.7%, thereby simulating fracture. Also bone stiffness was 
reported as an estimate of bone strength.
In our unit, CV ranged 0.4–0.8% for densities, 3.5–5.0% 
for trabecular microarchitecture parameters, 1.0–7.2% for 
extended cortical measures, and 1.2–1.7% for FE estimated 
failure load [22].
Blood Samples
Blood samples from patients and controls were analysed 
for ionized calcium, 25-hydroxy vitamin D and parathyroid 
hormone (PTH). In order to rule out exclusion criteria and 
potential competing reasons for amenorrhea (premature 
ovarian failure or hyperprolactinemia), blood samples were 
further analysed for thyroid-stimulating hormone (TSH), 
alkaline phosphatase (ALP), luteinizing hormone (LH), 
follicle-stimulating hormone (FSH) and prolactin.
Questionnaire
A questionnaire provided information on age at diagnosis 
of AN and duration of disease (patients) as well as informa-
tion on history of fracture, family history of osteoporosis, 
medical history, medication, alcohol and smoking habits 
(all participants).
Height and Weight
Height was measured on a wall-mounted stadiometer, and 
weight was measured on a calibrated platform scale. BMI 
was calculated as weight divided by the square of height 
(kg/m2).
Statistics
Normality of data was evaluated mathematically by the 
Shapiro–Wilk test and visually by normal probability plots. 
Non-normally distributed parameters were further evalu-
ated with histograms to determine distribution. Data are 
presented as mean +/− SD for normally distributed data 
or median and interquartile range for non-normally dis-
tributed data. Differences between groups were assessed 
using t-test, Wilcoxon–Mann–Whitney test or Moods 
median test, as appropriate. For evaluation of categorical 
outcomes, a Chi-squared test was used. As any potential 
effect of OCPs on bone microarchitecture in AN have not 
been studied, sensitivity analysis were required to assess 
the potential impact of OCP use on the HR-pQCT-derived 
parameters. Specifically, we performed multiple regression 
analysis, in order to adjust any potential effect of OCP use 
for the impact of BMI and duration of disease.
To estimate the association between bone measures and 
body weight, we performed seemingly unrelated regression 
(SUR) modelling [23]. In the regression, we assessed the 
difference in selected variables between patient and control 
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in each height-matched pair versus the difference in weight 
in the same pair. Thus, the regressions describe the pre-
dicted change in each variable when the patients weight 
decreases compared to controls. The difference between 
weight-bearing and non-weight-bearing bone, were then 
evaluated with a post estimation Wald test. All values in the 
regression analysis were adjusted for smoking.
A p value < 0.05 was considered significant. Stata (Ver-
sion 14.0, StataCorp, TX, US) was used for all statistical 
analysis.
Results
Study Subjects
A total of 28 patients were included in the study. Three 
patients were excluded before matching due to osteomala-
cia (n = 1), use of glucocorticoids (n = 1) and a height too 
low to obtain a match (153 cm, n = 1), as we did not con-
sider a randomly drawn control of similar height, repre-
sentative of the general population. No other subjects were 
identified with other diseases known to affect bone, or com-
peting reasons for amenorrhea. Thus, a total of 25 patients 
were eligible for matching.
Subject characteristics are shown in Table  1. Patients 
and controls did not differ in terms of age or height (due to 
matching), but as intended, in terms of weight, as well as 
body composition (fat percentage, fat mass and lean body 
mass). Controls had a younger mean age at menarche, com-
pared to AN cases (p < 0.05). Levels of ionized calcium, 
PTH and 25-hydroxy-vitamin D were not different between 
groups, nor were the number of subjects with values of 
25-hydroxy-vitamin D below reference range (six subjects 
in each group, data not shown). A higher prevalence of 
smoking as well as a history of at least one fracture was 
found in the patient group (p < 0.05 for both). The preva-
lence of OCP use was equal between groups.
DXA
BMC and BMD were significantly lower in patients com-
pared to controls, at all sites (p < 0.0001) (Table 2).
HR-pQCT
HR-pQCT results are shown in Table 3.
Distal Radius
In the non-weight-bearing radius, patients and controls 
did not differ in the geometric indices of outer bone 
perimeter, total bone area, cortical area, trabecular area 
or cortical thickness (Fig.  1). Trabecular vBMD was 
Table 1  Subject characteristics
Values are presented as mean ± SD or median and interquartile range, as appropriate
P values in bold indicates p < 0.05 on difference between groups
BMI body mass index, AN anorexia nervosa, PTH parathyroid hormone, OCP oral contraceptive pill
Characteristics AN (n = 25) Control (n = 25) p value
Age (years) 27.5 (23.8; 29.6) 27.9 (23.8; 31.4) 0.68
Height (cm) 166.6 ± 6.0 167.3 ± 6.0 0.71
Weight (kg) 44.8 ± 4.9 66.0 ± 9.2 <0.0001
BMI (kg/m2) 16.2 ± 1.25 22.8 ± 2.7 <0.0001
Age at menarche 12.9 ± 1.39 11.8 ± 0.89 <0.05
Duration of disease (years) 7.8 ± 4.4 –
Age at onset of AN (years) 20.0 (15.0; 22.0) –
Body composition
 Fat mass (kg) 9.0 ± 3.4 21.8 ± 7.0 <0.0001
 Fat percentage (%) 19.9 ± 6.4 31.8 ± 6.8 < 0.0001
 Lean mass (kg) 34.4 ± 3.6 42.3 ± 3.7 < 0.0001
Blood samples
 Ca2+ (mmol/L) 1.25 ± 0.05 1.23 ± 0.03 0.07
 25-OH vitamin D (nmol/L) 83 ± 47 70 ± 27 0.22
 PTH (pmol/L) 3.6 (1.8; 5.6) 3.9 (2.6; 5.0) 0.33
Current OCP use (yes/total) 9/25 7/25 0.54
Current smoker (yes/total) 12/25 4/25 <0.05
History of at least one fracture (yes/
total)
11/25 3/25 <0.05
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lower in patients compared to controls (p < 0.005), but no 
differences were found in cortical vBMD or total vBMD. 
In terms of microarchitecture, BV/TV was significantly 
lower in the patient group (p < 0.005), due to a lower 
Tb.N. (p < 0.001), but there was no difference in Tb.Th. 
Accordingly, Tb.Sp. was higher in the patient group 
(p < 0.001). Cortical porosity was comparable between 
groups. Estimates of the overall mechanical properties of 
the bone (stiffness and failure load) were markedly lower 
in the AN group, compared to controls (p < 0.001 and 
p < 0.0005, respectively).
Distal Tibia
In the weight-bearing tibia, outer bone perimeter and total 
bone area were comparable between groups. The cortex 
was significantly thinner in the patient group (p < 0.0005), 
the cortical area lower (p < 0.0001) and the trabecular 
area increased compared to controls, although the latter 
did not reach statistical significance (Fig.  2). Volumet-
ric BMD was significantly lower in both the cortical and 
trabecular departments, as well as total vBMD (p < 0.01; 
p < 0.0005; p < 0.0005, respectively). In terms of trabecular 
Table 2  DXA measurements
Values are presented as mean ± SD. P-values in bold indicates p < 0.05 on difference between groups
BMC bone mineral content, BMD bone mineral density
AN (n = 25) Controls (n = 25) p value
Femoral neck BMC (g) 3.04 ± 0.49 4.05 ± 0.62 <0.0001
Femoral neck BMD (g/cm2) 0.60 ± 0.10 0.79 ± 0.10 <0.0001
Trochanteric BMC (g) 5.31 ± 0.88 7.29 ± 1.15 <0.0001
Trochanteric BMD (g/cm2) 0.50 ± 0.07 0.68 ± 0.08 <0.0001
Total hip BMC (g) 23.3 ± 3.87 31.3 ± 4.65 <0.0001
Total hip BMD (g/cm2) 0.68 ± 0.11 0.91 ± 0.09 <0.0001
Total spine (L1–L4) BMC (g) 46.00 ± 10.2 59.1 ± 9.5 <0.0001
Total spine (L1–L4) BMD (g/cm2) 0.79 ± 0.13 0.99 ± 0.10 <0.0001
Table 3  HR-pQCT measures in patients and controls
Values are presented as mean ± SD or median and interquartile range, as appropriate. p values in bold indicates p < 0.05 on difference between 
groups
AN anorexia nervosa, vBMD volumetric bone mineral density, BV/TV. bone volume/tissue volume, Tb.Th. trabecular thickness, Tb.N. trabecular 
number, Tb.Sp. trabecular spacing
Geometry Radius Tibia
AN (n = 25) Controls (n = 25) p value AN (n = 25) Controls (n = 25) p value
Total bone area  (mm2) 251.9 ± 51.9 262.9 ± 47.8 0.56 680.7 ± 166.8 669.4 ± 119.2 0.78
Mean perimeter (mm) 66.2 ± 7.2 67.3 ± 6.2 0.56 101.0 ± 11.5 100.5 ± 8.7 0.86
Cortical area  (mm2) 46.0 ± 11.6 52.8 ± 11.7 0.06 92.4 ± 21.5 123.1 ± 20.7 <0.0001
Trabecular area  (mm2) 203.7 ± 54.9 206.5 ± 49.7 0.86 583.5 ± 177.9 545.2 ± 122.1 0.38
Cortical thickness (mm) 0.71 ± 0.23 0.79 ± 0.20 0.20 0.94 ± 0.29 1.24 ± 0.24 <0.0005
vBMD
Total vBMD (mg/cm3) 284.7 (229.6; 312.9) 298.8 (280.0; 340.1) 0.10 251.3 ± 72.5 320.1 ± 48.7 <0.0005
Cortical vBMD (mg/cm3) 861. ± 78.9 878.4 ± 56.6 0.17 882.5 (866.2; 901.8) 912.2 (903.6; 925.1) <0.01
Trabecular vBMD, mg/cm3 124.8 ± 35.9 155.7 ± 34.9 <0.005 137.1 ± 38.3 178.7 ± 31.0 <0.0005
Microarchitecture
BV/TV, [1] 0.104 ± 0.030 0.130 ± 0.029 <0.005 0.114 ± 0.032 0.150 ± 0.025 <0.0001
Tb.Th. (mm) 0.063 ± 0.012 0.067 ± 0.012 0.18 0.069 ± 0.012 0.078 ± 0.013 <0.01
Tb.N (1/mm) 1.64 ± 0.27 1.92 ± 0.29 <0.001 1.64 ± 0.26 1.93 ± 0.30 <0.001
Tb.Sp (mm) 0.563 (0.468; 0.625) 0.432 (0.400; 0.490) <0.001 0.554 ± 0.102 0.4512 ± 0.079 <0.0005
Cortical porosity (%) 0.72 (0.56; 1.15) 0.96 (0.63; 1.09) 0.55 2.65 (1.90; 3.59) 2.71 (2.21; 3.36) 0.70
Estimated strength
Stiffness 61,444 ± 12,520 74,868 ± 13,673 <0.001 162,158 ± 27,161 214,192 ± 33,105 <0.0001
Failure load (N) 3115 ± 612 3810 ± 675 <0.0005 8242 ± 1284 10,727 ± 1624 <0.0001
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Fig. 1  Mean percentage difference between patients and controls of measured geometric, volumetric and microarchitectural values in radius. 
Error bars indicate mean ± one standard deviation. *p value < 0.05
Fig. 2  Mean percentage difference between patients and controls of measured geometric, volumetric and microarchitectural values in tibia. 
Error bars indicate mean ± one standard deviation. *p value < 0.05
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microarchitecture, both trabecular number (p < 0.001), tra-
becular thickness (p < 0.01) and BV/TV (<0.0001) were 
lower in patients compared to controls, while trabecular 
spacing was higher in the patient group (p < 0.0005). Last, 
both stiffness and estimated failure load were markedly 
lower in the patient group (p < 0.0001 for both).
Sensitivity Analyses
There were no significant association between OCP use 
among patients with AN, and any parameter obtained from 
the HR-pQCT scans (Supplemental Table 1).
Regression Analysis
In the radius, decreasing weight in the patient group was 
associated with a decreasing Tb.N. and increasing Tb.Sp. 
(Table 4). For all other measures, there were no significant 
association to decreasing weight. In the tibia, decreasing 
patient weight was associated with a decrease in cortical 
thickness, Tb.N. and an increase in Tb.Sp. (Table 4). Both 
estimated measures of bone strength, stiffness and failure 
load decreased with decreasing weight.
When comparing the non-weight-bearing radius to the 
weight-bearing tibia, the regression coefficient differed sig-
nificantly for cortical thickness, stiffness and estimated fail-
ure load.
Discussion
In this cross-sectional study, we demonstrated differences 
in impairment between weight- and non-weight-bearing 
bones in AN, compared to normal weight controls. Key 
findings include (1) similar bone size between patients and 
controls, (2) a significant difference in cortical thickness in 
the tibia, but not in the radius and (3) a different associa-
tion between body weight and both cortical thickness and 
estimated failure load in weight-bearing versus non-weight-
bearing bone.
In the inclusion, we allowed for the use of OCP in both 
patient and control groups. The decision was based on the 
systemic review and meta-analyses by Sim et  al. which 
failed to show a convincing effect of OCPs on BMD [24], 
and to the best of our knowledge, no effect of OCPs on 
bone geometry or microarchitecture has been shown. As 
OCPs are widely used in clinical populations of AN, exclu-
sion of OCP users could be a threat to the external valid-
ity of the study. Reassuringly, sensitivity analyses on our 
data showed no independent effect of OCP use on any of 
the parameters derived from the HR-pQCT scans (Supple-
mental Table 1).
The finding of comparable bone perimeter and total 
bone area between patients and controls in both the radius 
and the tibia holds important implications. During growth, 
periosteal apposition exceeds endocortical resorption, 
mediating expansion of the bone and an increase in cortical 
thickness [25]. If the process of periosteal deposition was 
significantly impaired as a consequence of malnutrition and 
low weight in AN, a smaller bone perimeter was expected 
in the AN group, with the effect being most pronounced in 
patients with debut of disease at an early age. This, how-
ever, was not the case, nor when stratifying for age at onset 
of disease (data not shown). Our findings are in line with 
other HR-pQCT studies [26, 27] comparing patients with 
AN to normal weight controls, suggesting that decreased 
periosteal apposition is not the cause of bone impairment 
in AN.
Table 4  Regressions on 
HR-pQCT-derived measures 
and body weight. Estimates 
reflects the predicted change, 
when the weight of the patients, 
compared to controls, decreases 
with one kg
Radius versus tibia reflects comparison of β-coefficients from the radius and tibia regressions. Values are 
adjusted for smoking. p values in bold indicates p < 0.05
vBMD volumetric bone mineral density, BV/TV bone volume/tissue volume, Tb.Th. trabecular thickness, 
Tb.N. trabecular number, Tb.Sp. trabecular spacing
Radius Tibia Radius versus tibia
Estimate p value Estimate p value p value
Total vBMD (mg/cm3) −1.31 0.40 −2.29 0.12 0.30
Trabecular vBMD (mg/cm3) −1.11 0.23 −0.72 0.45 0.51
Cortical vBMD (mg/cm3) −0.84 0.65 −1.64 0.16 0.70
Cortical thickness, mm −0.003 0.62 −0.012 <0.05 <0.05
BV/TV −0.0009 0.24 −0.0004 0.61 0.59
Tb.N. (1/mm) −0.02 <0.05 −0.02 <0.01 0.81
Tb.Th. (mm) 0.0002 0.54 0.0004 0.08 0.52
Tb.Sp. (mm) 0.006 <0.05 0.006 <0.05 0.97
Stiffness −394 0.25 −1720 <0.05 <0.05
Failure load (N) −19.0 0.26 −90.8 <0.05 <0.01
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In our study, cortical thickness was lower in the AN 
group in the weight-bearing tibia, but not in the non-
weight-bearing radius (Fig.  1). Previous studies have 
shown significant cortical thinning in the radius as well [4, 
26], possible due to an earlier onset of disease, compared 
to participants in our sample. In support of our results, at 
least one other study has shown that the magnitude of corti-
cal thinning is higher in the tibia compared to the radius 
[27]. Thus, it seems that the overall impact of AN on cor-
tical bone geometry is on the endocortical surface, either 
as a result of decreased formation during growth, or as 
increased resorption later on, but also that there may be a 
site-specific difference.
This proposed pattern of impaired cortical bone geom-
etry, seems at least in part to resemble that of female meno-
pause, exemplified by Szulc et al. [28] and later by Shan-
bhogue et  al. [29]. Based on longitudinal assessment of 
healthy subjects, both studies highlight cortical thinning 
due to endocortical resorption as a hallmark of bone loss in 
postmenopausal women, but not in men [29], suggesting a 
potential role of estrogen. A possible link between estrogen 
deficiency and cortical bone loss in weight-bearing vs. non-
weight-bearing bones, have been proposed by Lee et  al. 
[30]. In a study on mice comparing a mouse strain lack-
ing the estrogen receptor alpha (ER-alpha), with a strain 
with functional ER-alpha receptors, the effect of repeated 
mechanical loading on cortical area was diminished three-
fold in the knockout strain. In accordance, although not in 
patients with AN, a Finnish study including 245 girls aged 
10–13 years, showed that polymorphisms of the ER-alpha 
gene modulated the effect of loading on weight-bearing, 
but not in non-weight-bearing bone [31]. Thus, it is possi-
ble that the difference in cortical thickness between weight-
bearing and non-weight-bearing bone in our study was, at 
least in part, due to lower mechanical load, and that the 
effect might have been modulated by the lack of estrogen.
We report impaired trabecular microarchitecture in both 
the radius and the tibia. The pattern of trabecular bone 
impairment is comparable between the weight-bearing 
and non-weight-bearing bone, with lower values for BV/
TV and Tb.N. and higher Tb.Sp. Even though there was no 
significant difference in total vBMD between groups in the 
radius, patients had markedly lower FEA-derived estimated 
failure load in both the radius and the tibia. This appar-
ent divergence highlights that trabecular microarchitecture 
adds to calculated bone strength, beyond BMD. In post-
menopausal women, a recent multicentre study found tra-
becular microarchitecture to modestly improve the discrim-
ination of women with and without fracture independently 
of aBMD at the hip and vBMD at the radius or tibia [32]. 
Similar studies are yet to be made in an AN population. As 
forearm fractures are twice as prevalent in AN compared to 
healthy controls of same age [9], focusing on vBMD alone 
would probably cause an underestimation of fracture risk in 
our sample of patients.
In the regression analyses, we assessed the associa-
tion between body weight and HR-pQCT variables, tak-
ing advantage of patients and controls being matched on 
height. This association was obviously confounded by dis-
ease severity, as a large weight difference between patient 
and control would most likely mean that the patient was 
more affected by malnutrition, compared to a patient-con-
trol pair with a smaller weight difference. By comparing 
weight-bearing to non-weight-bearing bone in each patient-
control pairs, we were able to minimize this confounding 
issue. We report a positive association between weight and 
the predicted cortical thickness in tibia, but not in the radius 
(Table  4). If the relationship between weight and cortical 
thickness were solely due to weight serving as a proxy for 
disease severity, we would not expect a difference between 
weight-bearing and non-weight-bearing bone. Thus, the 
reported difference might be explained by mechanical load-
ing enforced by body weight. On the contrary, predicted 
Tb.N. did decrease with decreasing patient weight, but 
there were no difference between weight-bearing and non-
weight-bearing bone, making a role of mechanical loading, 
less likely. Finally, we found no significant association of 
predicted estimated failure load to weight in the radius, but 
a significant association in the tibia, again suggesting a role 
of body weight on estimated bone strength.
So what is the clinical implication of the proposed role 
of mechanical loading on cortical bone geometry and bone 
strength in weight-bearing bone? Is it an irreversible con-
sequence of the disease or a reversible adaptation to low 
weight? The mechanical strength of the weight-bearing 
bone is without doubt decreased in AN, but so is the bio-
mechanical requirements due to the decreased weight. Only 
longitudinal studies can show how bone microarchitecture 
respond to nutritional rehabilitation in AN, and define the 
prognostic potential in predicting fracture compared to 
aBMD.
Strength and Limitations
The methodological strengths of our study include match-
ing tightly on height. When including subjects of differ-
ent height (and thereby different length of the bones), the 
region of interest is not identical between subjects. Shan-
bhogue et  al. recently highlighted the importance of this 
methodological issue [33]. In their study comparing fixed 
offset to an offset relative to bone length, they report mor-
phologic variation with varying measurement position, up 
to as much as 34% in the radius and 36% in the tibia. As 
height is highly correlated to arm and leg length in subjects 
of the same race, gender and age, we ensured agreement 
on regions of interest between groups, thereby making the 
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direct comparison reliable. Another important strength was 
the random recruitment of control subjects, making the 
sample more likely to reflect the general population.
Important limitations include the cross-sectional design 
of the study, which especially relates to the emphasis on 
body weight. We recorded body weight at the day of the 
examination, but clearly the patient’s bones are affected by 
weight and disease-severity over time. A dramatic weight-
change (either way) just before the examination could alter 
the relationship between weight and the measured vari-
ables. Smoking turned out to be more prevalent in the AN 
group, which represents a potential issue, as smoking is 
associated to decreased BMD and increased fracture risk 
[34]. However, as we adjusted for smoking in the regres-
sion analyses, the estimates are not affected by this in-bal-
ance in smoking prevalence. Finally, we did not adjust the 
HR-pQCT measurements for multiple testing. As the direc-
tion and magnitude of the measured difference between 
patients and controls were both consistent and intuitive 
throughout our data, we consider the risk of making a type 
1 error unlikely, although it cannot be fully dismissed.
Conclusion
In this cross-sectional study, we found significantly lower 
bone mass and impaired bone microarchitecture in adult 
AN patients, compared to normal weight controls. Fur-
thermore, we demonstrate differences in bone impairment 
between weight-bearing and non-weight-bearing bone, 
implying an effect of the lower mechanical loading on bone 
geometry and microarchitecture in AN. Longitudinal stud-
ies are needed to show whether these changes are a revers-
ible adaption to decreased mechanical needs, or represent 
irreversible damage to the skeleton, with implication also 
for long-term fracture risk in these patients.
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